Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Imaging of Proteins in Tissue Samples Using Nanospray Desorption Electrospray Ionization Mass Spectrometry.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Neuropsychological, balance and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
Fingolimod and cardiac risk: latest findings and clinical implications.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Therapy of NMO spectrum disorders.
Brain cytokines and disease.
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Management of faecal incontinence and constipation in adults with central neurological diseases.

Pages